Implementation of Substance Use Treatment in Ambulatory Care

Provides a sample consent for treatment with buprenorphine/naloxone.

Provides a sample consent for treatment with buprenorphine/naloxone.

Provides information on services covered by the Medicare Physician Fee Schedule.

Presents a business plan for health centers and practices who treat opioid use disorder (OUD).

Offers a learning activity that includes different clinical models of buprenorphine induction, associated evidence, and pros and cons of each.

Gives medical professionals tools and resources to screen their patients for tobacco, alcohol, illicit drug, and nonmedical prescription drug use. Includes resources such as an online screening tool, a companion quick reference guide, and a comprehensive resource guide for clinicians.

Provides guidance about the use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with or at risk of addiction. Links to additional resources, such as a pocket guide and a slide deck.

Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.

Describes service delivery models and corresponding rate design tools for the provision of MAT to individuals with opioid dependence.

Provides resources for clinicians interested in initiating buprenorphine treatment in emergency department settings.